10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Dr. Lal PathLabs's 10-Year ROIIC % for the quarter that ended in Mar. 2024 was 19.23%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Dr. Lal PathLabs's 10-Year ROIIC % or its related term are showing as below:
NSE:LALPATHLAB's 10-Year ROIIC % is ranked better than 78.85% of 208
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.25
vs NSE:LALPATHLAB: 19.23
Dr. Lal PathLabs 10-Year ROIIC % Historical Data
The historical data trend for Dr. Lal PathLabs's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dr. Lal PathLabs's 10-Year ROIIC %
For the Diagnostics & Research subindustry, Dr. Lal PathLabs's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Lal PathLabs's 10-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Dr. Lal PathLabs's 10-Year ROIIC % falls into.
Dr. Lal PathLabs 10-Year ROIIC % Calculation
Dr. Lal PathLabs's 10-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Dr. Lal PathLabs (NSE:LALPATHLAB) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Dr. Lal PathLabs 10-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Dr. Lal PathLabs's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:LALPATHLAB has been successfully added to your 